TDEM Highlights COVID-19 Funding Opportunities
Sep 9, 2020,
17:58 PM
by
Melodi Moore
The Texas Division of Emergency Management (TDEM) has advised that there is still funding available for COVID-19 related activities. Although many of these opportunities have appeared on the Research Services Blog before, we wanted to show them again for your convenience.
|
Opportunity No.
|
Name
|
Sponsor
|
Posted/Forecasted
|
Posted Date
|
Due Date
|
|
RFA-OD-20-020
|
Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (R44 Clinical Trial Not Allowed)
|
HHS-NIH11
|
Posted
|
08/06/2020
|
09/18/2020
|
|
OS-PAW-20-001
|
SARS-CoV-2 (COVID-19) Program Activities
|
HHS-OPHS
|
Forecasted
|
07/10/2020
|
|
|
RFA-OD-20-017
|
Emergency Awards RADx-RAD: Screening for COVID-19 by Electronic-Nose Technology (SCENT) (U18 Clinical Trial Not Allowed)
|
HHS-NIH11
|
Posted
|
08/06/2020
|
09/18/2020
|
|
RFA-OD-20-022
|
Emergency Awards: Chemosensory Testing as a COVID-19 Screening Tool (U01 Clinical Trial Optional)
|
HHS-NIH11
|
Posted
|
08/06/2020
|
09/15/2020
|
|
RFA-OD-20-021
|
Emergency Awards RADx-RAD: Novel Biosensing for Screening, Diagnosis and Monitoring of COVID-19 From Skin and The Oral Cavity (Fast-Track STTR Clinical Trial Not Allowed)
|
HHS-NIH11
|
Posted
|
08/06/2020
|
09/18/2020
|
|
SFOP0007233
|
2020 TIP Office Annual Program Statement to Address the Impacts of COVID-19
|
DOS-GTIP
|
Posted
|
08/14/2020
|
06/30/2021
|
|
PAR-20-243
|
Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional)
|
HHS-NIH11
|
Posted
|
06/25/2020
|
03/02/2021
|
|
RFA-OD-20-015
|
Emergency Awards: RADx-rad Wastewater Detection of SARS-COV-2 (COVID-19) (U01 - Clinical Trials Not Allowed)
|
HHS-NIH11
|
Posted
|
08/06/2020
|
09/15/2020
|
|
SFOP0007088
|
COVID-19 Private Sector Engagement & Partnership Fund
|
DOS-SBUR
|
Posted
|
08/05/2020
|
05/28/2021
|
|
PAR-20-237
|
Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional)
|
HHS-NIH11
|
Posted
|
06/17/2020
|
12/01/2020
|
|
PAR-20-234
|
NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required)
|
HHS-NIH11
|
Posted
|
06/15/2020
|
02/01/2021
|
|
RFA-DK-20-021
|
Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional)
|
HHS-NIH11
|
Posted
|
07/10/2020
|
12/16/2020
|
|
PAR-20-256
|
Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed)
|
HHS-NIH11
|
Posted
|
07/13/2020
|
07/07/2021
|
|
|
|
|
|
|
|
|
RFA-TR-20-003
|
Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required)
|
HHS-NIH11
|
Posted
|
08/05/2020
|
01/23/2021
|
|
RFA-OD-20-016
|
Emergency Awards: RADx-RAD Multimodal COVID-19 surveillance methods for high risk clustered populations (R01 Clinical Trial Optional)
|
HHS-NIH11
|
Posted
|
08/06/2020
|
09/30/2020
|